Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
Sjoukje F. Oosting, Astrid A.M. van der Veldt, Rudolf S.N. Fehrmann, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 7, pp. 833-835
Open Access | Times Cited: 25

Showing 25 citing articles:

Immunogenicity and Safety of COVID-19 Vaccines in Patients with Pancreatic Cancer
Leonoor V. Wismans, Rory D. de Vries, Casper W.F. van Eijck, et al.
HPB (2025)
Open Access
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
Sruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh Bayry
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108399-108399
Open Access | Times Cited: 12
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
Helen Kakkassery, Esme Carpenter, Piers Patten, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 12, pp. 1082-1099
Open Access | Times Cited: 18
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
K. L. Juliëtte Schmidt, Noël Dautzenberg, Peter M. Hoogerbrugge, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2562-2562
Open Access | Times Cited: 10
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer
Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 3, pp. 635-646
Open Access | Times Cited: 14
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
Rita Carsetti, Chiara Agrati, Valeria Pinto, et al.
Blood (2022) Vol. 140, Iss. 15, pp. 1735-1738
Open Access | Times Cited: 12
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 651-662
Open Access | Times Cited: 12
Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
Enben Su, Stefanie Fischer, R. Demmer-Steingruber, et al.
ESMO Open (2022) Vol. 7, Iss. 5, pp. 100587-100587
Open Access | Times Cited: 11
The impact of COVID-19 on cancer patients
Demi Wekking, Thilini H. Senevirathne, Josie Pearce, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 110-118
Closed Access | Times Cited: 5
COVID-19 vaccination and liver disease
Sotaro Ozaka, Takashi Kobayashi, Kazuhiro Mizukami, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6791-6810
Open Access | Times Cited: 9
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
Anastasia Gangaev, Yannick van Sleen, Nicole Brandhorst, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment
Karin Purshouse, John P. Thomson, Mahéva Vallet, et al.
The Oncologist (2023) Vol. 28, Iss. 3, pp. e145-e155
Open Access | Times Cited: 4
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
Amy Body, Luxi Lal, Sriganesh Srihari, et al.
Vaccine (2024), pp. 126547-126547
Open Access | Times Cited: 1
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors
Fabrizio Nelli, Diana Giannarelli, Agnese Fabbri, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 10, pp. 3217-3228
Open Access | Times Cited: 3
One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment
Astrid A.M. van der Veldt, Sjoukje F. Oosting, Rudolf S.N. Fehrmann, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100785-100785
Open Access | Times Cited: 2
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors
Sjoukje F. Oosting, Astrid A.M. van der Veldt, Rudolf S.N. Fehrmann, et al.
ESMO Open (2023) Vol. 8, Iss. 4, pp. 101599-101599
Open Access | Times Cited: 2
Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients
Davide Dalu, Maciej Tarkowski, Lorenzo Ruggieri, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 8, pp. 1371-1376
Open Access | Times Cited: 2
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination
Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)
Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5547-5547
Open Access | Times Cited: 2
COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Kan Yonemori
International Cancer Conference Journal (2023) Vol. 12, Iss. 3, pp. 216-219
Open Access
Data from Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer
Yana Debie, Jonas R.M. Van Audenaerde, Timon Vandamme, et al.
(2023)
Open Access
Research Progress of COVID-19 Vaccination in Patients with Chronic Liver Diseases
必琼 张
Advances in Clinical Medicine (2023) Vol. 13, Iss. 06, pp. 9060-9066
Closed Access
Effects of the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine on immune-related adverse events and disease outcomes in cancer patients receiving immune checkpoint inhibitors
Fabrizio Nelli, Diana Giannarelli, Agnese Fabbri, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top